The Clinton Health Access Initiative Inc. (CHAI) is a global health organization committed to our mission of saving lives and reducing the burden of disease in low-and middle-income countries. We work at the invitation of governments to support them and the private sector to create and sustain high-quality health systems.
CHAI was founded in 2002 in response to the HIV/AIDS epidemic with the goal of dramatically reducing the price of life-saving drugs and increasing access to these medicines in the countries with the highest burden of the disease. Over the following two decades CHAI has expanded its focus. Today along with HIV we work in conjunction with our partners to prevent and treat infectious diseases such as COVID-19 malaria tuberculosis and hepatitis. Our work has also expanded into cancer diabetes hypertension and other non-communicable diseases and we work to accelerate the rollout of lifesaving vaccines reduce maternal and child mortality combat chronic malnutrition and increase access to assistive technology. We are investing in horizontal approaches to strengthen health systems through programs in human resources for health digital health and health financing. With each new and innovative program our strategy is grounded in maximizing sustainable impact at scale ensuring that governments lead the solutions that programs are designed to scale nationally and learnings are shared globally.
At CHAI our people are our greatest asset and none of this work would be possible without their talent time dedication and passion for our mission and values. We are a highly diverse team of enthusiastic individuals across 40 countries with a broad range of skillsets and life experiences. CHAI is deeply grounded in the countries we work in with majority of our staff based in program countries.
WJCF is an Indian not-for-profit entity registered under Section 8 of the Indian Companies Act 2013 and has an affiliation agreement with the Clinton Health Access Initiative (CHAI). Our mission is to save lives and improve health outcomes in the country by enabling the government and private sector to strengthen and sustain quality health systems. WJCF has partnered with the Ministry of Health & Family Welfare and state health departments since 2007 providing technical and operational support across key health priorities including infectious diseases (COVID-19 hepatitis HIV TB vector-borne diseases) non-communicable diseases (cervical cancer diabetes sickle cell disease) maternal and child health (anaemia immunisation diarrhoea pneumonia) sexual and reproductive health health insurance and digital health (AB PM-JAY ABDM) oxygen and hypoxemia management safe drinking water and climate and health.
Learn more about our exciting work:
Programme Overview:
Vector Borne Diseases (VBDs) such as malaria visceral leishmaniasis (VL also called kala-azar) lymphatic filariasis (LF) dengue chikungunya and Japanese encephalitis remain major public health concerns in India.
India has achieved remarkable reductions in VBD cases and deaths over recent decades. Malaria cases have reduced from 75 million at the time of Indias independence to 20000 in 2023-24 while deaths have reduced from 800000 to 83 during the same period. For LF though active transmission and infection rates have declined the chronic manifestations remain significant. India reported about 60000 lymphoedema cases and 125000 hydrocele cases caused by filarial worms in 2023. For VL cases have reduced to 500 in 2023. The Government of India has committed to the elimination of several VBDs within defined timelines- for example eliminating malaria by 2030 and lymphatic filariasis and kala-azar ahead of global targets.
Despite these gains these illnesses continue to contribute substantially to disease burden morbidity mortality and disability particularly among populations living in rural remote or otherwise underserved areas. Climate change urbanization migration environmental factors and gaps in vector control and surveillance continue to challenge disease elimination efforts.
The National Center for Vector Borne Diseases Control (NCVBDC) is the nodal agency under the National Vector Borne Disease Control Programme (NVBDCP) responsible for orchestrating the governments response to VBDs. Its roles include policy formulation standard setting strategic planning (including disease elimination timelines) surveillance strengthening capacity building coordinating multi-sectoral and inter-governmental efforts and deploying innovations in vector control diagnostics and community engagement.
Project Background:
WJCF is privileged to support NVBDCPs bold vision of accelerated elimination of VL and LF through an embedded technical support unit (TSU) since 2020. This TSU provides support to the NCVBDC including inter alia:
Position Summary:
WJCF is seeking a highly motivated individual with outstanding credentials and demonstrated M&E abilities to work within NCVBDC. The M&E Associate will provide technical support in strengthening quality program management including M&E to facilitate data-driven decision-making strengthening data recording and reporting mechanisms and support governance and capacity building initiatives. They would also deliver critical and on-demand program insights by leveraging multiple data sources and field insights. They will support data collation analysis and visualization and identification of innovative approaches/technologies to support the elimination goals. The Associate will report to the Lead for the VBD TSU.
Last Date to Apply: 6th February 2026
Required Experience:
IC
The Clinton Health Access Initiative, Inc. (CHAI) is a global health organization committed to saving lives and reducing the burden of disease in low-and middle-income countries.